BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Phoenix
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261104
DTEND;VALUE=DATE:20261107
DTSTAMP:20260505T061045Z
CREATED:20260505T061045Z
LAST-MODIFIED:20260505T061045Z
UID:10000283-1793750400-1794009599@melanoma.org.au
SUMMARY:ESSO Congress
DESCRIPTION:The Annual Congress of the European Society of Surgical Oncology (ESSO) is the leading event in Europe dedicated to advancing surgical cancer care. \nBringing together oncology surgeons\, researchers\, and healthcare professionals from across the globe\, the ESSO Congress offers a dynamic platform for sharing cutting-edge research\, surgical innovations\, and multidisciplinary approaches to cancer treatment. \nWith a strong focus on education\, collaboration\, and excellence in patient outcomes\, the congress fosters dialogue\, drives progress\, and shapes the future of surgical oncology. \nWith the theme Surgical Oncology without Borders: Innovations and Challenges Worldwide\, we will explore the latest advancements\, global perspectives\, and shared challenges that shape the future of Surgical Oncology around the world. \nLocation: IFEMA Madrid\, Spain \nKey Dates: \nAbstract submission deadline: 6 May 2026\nAbstract review results: 6 July 2026\nEarly registration deadline: 19 August 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/esso_congress/
LOCATION:IFEMA Madrid\, Avda. Del Partenon\, 5\, Madrid\, 28042\, Spain
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/04/ESSO_2026_1-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261104
DTEND;VALUE=DATE:20261109
DTSTAMP:20260506T001943Z
CREATED:20260505T061518Z
LAST-MODIFIED:20260506T001943Z
UID:10000284-1793750400-1794182399@melanoma.org.au
SUMMARY:SITC Annual Meeting
DESCRIPTION:SITC 2026 is the premier international conference focused on cancer immunotherapy\, bringing together leaders from academia\, regulatory agencies\, government\, and industry for education\, scientific exchange\, and networking. \nThe conference provides a multidisciplinary educational and interactive environment focused on improving outcomes for cancer patients by incorporating strategies based on basic and applied cancer immunotherapy. \nWhy attend SITC 2026? \n\nCutting-edge sessions by IO experts (Don’t miss over 40 sessions on the latest IO research)\nIn-person networking opportunities with IO luminaries\nAccess the latest immuno-oncology research\n\nLocation: Phoenix Convention Center\, Phoenix\, Arizona\, United States \nKey Dates: \nRegular and early career investigator award abstract submission deadline: 25 June 2026\nAbstract notifications: 31 July 2026\nLate-breaking abstract submission deadline: 10 September 2026\nAbstract notifications: 28 September 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/sitc_meeting/
LOCATION:Phoenix Convention Center\, 100 N 3rd Street\, Phoenix\, AZ\, United States
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/04/SITC_2026-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20261104T170000
DTEND;TZID=Australia/Sydney:20261104T170000
DTSTAMP:20260804T062313Z
CREATED:20260804T054341Z
LAST-MODIFIED:20260804T062313Z
UID:10000323-1793811600-1793811600@melanoma.org.au
SUMMARY:NHMRC Clinical Trials and Cohort Studies Grants
DESCRIPTION:Clinical Trials and Cohort Studies Grants support high-quality clinical trials and cohort studies that address important gaps in knowledge\, leading to relevant and implementable findings for the benefit of human health. \nThis funding scheme is open to research proposals for clinical trials and/or cohort studies of any size – that is\, they may be large or small clinical trials or cohort studies. \nThe intended outcomes of the Clinical Trials and Cohort Studies Grants scheme are improvements in health and well-being\, health care practice or policy\, as a result of: \n\nHigh-quality clinical trials that provide reliable evidence of the effects of health-related interventions on health outcomes (or appropriate surrogates).\nHigh-quality cohort studies that provide reliable evidence on the relation of important risk factors and other exposures to health-related outcomes.\nHigh quality retrospective cohort studies that provide reliable evidence on the relation of important risk factors and other exposures to health-related outcomes.\n\n\nKey Dates:\nApplications open: 9 September 2026\nMinimum data due date: 7 October 2026\nApplications close: 4 November 2026 \nGuidelines will be available when the grant opens. \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-clinical-trials-grants/
CATEGORIES:Grants,Clinical Trial Cohorts
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/07/NHMRC_Clinical_Trials_Grants-600-x-338-px.jpg
END:VEVENT
END:VCALENDAR